{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T01:47:02Z","timestamp":1788572822630,"version":"build-2803163510"},"reference-count":62,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T00:00:00Z","timestamp":1741305600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003762","name":"Institut Pasteur","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003762","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Nucleic Acids"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.omtn.2025.102514","type":"journal-article","created":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T12:27:32Z","timestamp":1741782452000},"page":"102514","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["A Lyme disease mRNA vaccine targeting Borrelia burgdorferi OspA induces strong immune responses and prevents transmission in mice"],"prefix":"10.1016","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3061-9747","authenticated-orcid":false,"given":"Djamel","family":"Tahir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginie","family":"Geolier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugo","family":"Bruant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Le Fl\u00e8che-Mat\u00e9os","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adeline","family":"Mallet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Varloud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9line","family":"Civat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves","family":"Girerd-Chambaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandrine","family":"Montano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinne","family":"Pion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Ferquel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Pavot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Choumet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtn.2025.102514_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2807\/1560-7917.ES.2017.22.27.30569","article-title":"Surveillance perspective on Lyme borreliosis across the European Union and European Economic Area","volume":"22","author":"van den Wijngaard","year":"2017","journal-title":"Euro Surveill."},{"key":"10.1016\/j.omtn.2025.102514_bib2","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1146\/annurev-genet-011112-112140","article-title":"Genetics of Borrelia burgdorferi","volume":"46","author":"Brisson","year":"2012","journal-title":"Annu. Rev. Genet."},{"key":"10.1016\/j.omtn.2025.102514_bib3","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1128\/jcm.31.2.340-350.1993","article-title":"An OspA serotyping system for Borrelia burgdorferi based on reactivity with monoclonal antibodies and OspA sequence analysis","volume":"31","author":"Wilske","year":"1993","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.omtn.2025.102514_bib4","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/j.1469-0691.2011.03492.x","article-title":"The Expanding Lyme Borrelia Complex-Clinical Significance of Genomic Species?","volume":"17","author":"Stanek","year":"2011","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.omtn.2025.102514_bib5","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1128\/JCM.42.3.1316-1318.2004","article-title":"First Isolation of Borrelia lusitaniae from a Human Patient","volume":"42","author":"Collares-Pereira","year":"2004","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.omtn.2025.102514_bib6","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.3201\/eid2708.204763","article-title":"Comparison of Lyme Disease in the United States and Europe","volume":"27","author":"Marques","year":"2021","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.omtn.2025.102514_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.ttbdis.2019.101359","article-title":"Vector competence studies with hard ticks and Borrelia burgdorferi sensu lato spirochetes: A review","volume":"11","author":"Eisen","year":"2020","journal-title":"Ticks Tick. Borne. Dis."},{"key":"10.1016\/j.omtn.2025.102514_bib8","series-title":"Lyme Borreliosis","first-page":"51","article-title":"Clinical Manifestations and Diagnosis of Lyme Borreliosis","author":"Strle","year":"2009"},{"key":"10.1016\/j.omtn.2025.102514_bib9","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.cll.2010.01.003","article-title":"Lyme disease","volume":"30","author":"Murray","year":"2010","journal-title":"Clin. Lab. Med."},{"key":"10.1016\/j.omtn.2025.102514_bib10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0116767","article-title":"Health Care Costs, Utilization and Patterns of Care following Lyme Disease","volume":"10","author":"Adrion","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.omtn.2025.102514_bib11","article-title":"Post-Treatment Lyme Disease Syndrome: Need for Diagnosis and Treatment","volume":"13","author":"Maksimyan","year":"2021","journal-title":"Cureus"},{"key":"10.1016\/j.omtn.2025.102514_bib12","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1186\/s12889-019-6681-9","article-title":"Estimation of cumulative number of post-treatment Lyme disease cases in the US, 2016 and 2020","volume":"19","author":"DeLong","year":"2019","journal-title":"BMC Public Health"},{"key":"10.1016\/j.omtn.2025.102514_bib13","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1089\/vbz.2017.2127","article-title":"Brave New Worlds: The Expanding Universe of Lyme Disease","volume":"17","author":"Stone","year":"2017","journal-title":"Vector Borne Zoonotic Dis."},{"key":"10.1016\/j.omtn.2025.102514_bib14","first-page":"191","article-title":"Human and Veterinary Vaccines for Lyme Disease","volume":"42","author":"O\u2019Bier","year":"2021","journal-title":"Curr. Issues Mol. Biol."},{"key":"10.1016\/j.omtn.2025.102514_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1574-695X.2012.00980.x","article-title":"The role of Borrelia burgdorferi outer surface proteins","volume":"66","author":"Kenedy","year":"2012","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"10.1016\/j.omtn.2025.102514_bib16","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41541-020-0183-8","article-title":"Design of a broadly reactive Lyme disease vaccine","volume":"5","author":"Kamp","year":"2020","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.omtn.2025.102514_bib17","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1080\/14760584.2022.2102484","article-title":"Past, present, and future of Lyme disease vaccines: antigen engineering approaches and mechanistic insights","volume":"21","author":"Chen","year":"2022","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.omtn.2025.102514_bib18","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/s41541-022-00429-5","article-title":"The year that shaped the outcome of the OspA vaccine for human Lyme disease","volume":"7","author":"Dattwyler","year":"2022","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.omtn.2025.102514_bib19","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.pt.2007.07.001","article-title":"Tick\u2013host\u2013pathogen interactions in Lyme borreliosis","volume":"23","author":"Hovius","year":"2007","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.omtn.2025.102514_bib20","doi-asserted-by":"crossref","first-page":"3313","DOI":"10.1128\/IAI.73.6.3313-3321.2005","article-title":"Immunoglobulin-regulated expression of Borrelia burgdorferi outer surface protein A in vivo","volume":"73","author":"Hodzic","year":"2005","journal-title":"Infect. Immun."},{"key":"10.1016\/j.omtn.2025.102514_bib21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0113294","article-title":"Design and Development of a Novel Vaccine for Protection against Lyme Borreliosis","volume":"9","author":"Comstedt","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.omtn.2025.102514_bib23","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1056\/NEJM199807233390402","article-title":"A Vaccine Consisting of Recombinant Borrelia burgdorferi Outer-Surface Protein A to Prevent Lyme Disease","volume":"339","author":"Sigal","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.omtn.2025.102514_bib22","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1056\/NEJM199807233390401","article-title":"Vaccination against Lyme Disease with Recombinant Borrelia burgdorferi Outer-Surface Lipoprotein A with Adjuvant","volume":"339","author":"Steere","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.omtn.2025.102514_bib24","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1542\/peds.108.1.123","article-title":"Safety and Immunogenicity of a Recombinant Borrelia burgdorferi Outer Surface Protein A Vaccine Against Lyme Disease in Healthy Children and Adolescents: A Randomized Controlled Trial","volume":"108","author":"Sikand","year":"2001","journal-title":"Pediatrics"},{"key":"10.1016\/j.omtn.2025.102514_bib25","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1086\/514779","article-title":"Alternative Vaccination Schedules (0, 1, and 6 Months Versus 0, 1, and 12 Months) for a Recombinant OspA Lyme Disease Vaccine","volume":"28","author":"Van Hoecke","year":"1999","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.omtn.2025.102514_bib26","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1086\/315359","article-title":"Growth-Inhibiting Antibody Responses of Humans Vaccinated with Recombinant Outer Surface Protein A or Infected with Borrelia burgdorferi or Both","volume":"181","author":"Luke","year":"2000","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.omtn.2025.102514_bib27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0184357","article-title":"The novel Lyme borreliosis vaccine VLA15 shows broad protection against Borrelia species expressing six different OspA serotypes","volume":"12","author":"Comstedt","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.omtn.2025.102514_bib28","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1016\/S1473-3099(23)00210-4","article-title":"Safety and immunogenicity of a novel multivalent OspA-based vaccine candidate against Lyme borreliosis: a randomised, phase 1 study in healthy adults","volume":"23","author":"B\u00e9zay","year":"2023","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.omtn.2025.102514_bib29","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.1016\/j.ymthe.2023.07.022","article-title":"Development of an mRNA-lipid nanoparticle vaccine against Lyme disease","volume":"31","author":"Pine","year":"2023","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2025.102514_bib30","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.3390\/pharmaceutics15071972","article-title":"Recent Advancement in mRNA Vaccine Development and Applications","volume":"15","author":"Al Fayez","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.omtn.2025.102514_bib31","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2013.00006","article-title":"Vaccination against Lyme disease: past, present, and future","volume":"3","author":"Embers","year":"2013","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.omtn.2025.102514_bib32","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1016\/S0264-410X(96)00146-6","article-title":"Evaluation of the safety, reactogenicity and immunogenicity of three recombinant outer surface protein (OspA) lyme vaccines in healthy adults","volume":"14","author":"Van Hoecke","year":"1996","journal-title":"Vaccine"},{"key":"10.1016\/j.omtn.2025.102514_bib33","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/infdis\/jiw151","article-title":"Pre-exposure Prophylaxis With OspA-Specific Human Monoclonal Antibodies Protects Mice Against Tick Transmission of Lyme Disease Spirochetes","volume":"214","author":"Wang","year":"2016","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.omtn.2025.102514_bib34","doi-asserted-by":"crossref","first-page":"616","DOI":"10.3201\/eid2702.202731","article-title":"Estimating the Frequency of Lyme Disease Diagnoses, United States, 2010\u20132018","volume":"27","author":"Kugeler","year":"2021","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.omtn.2025.102514_bib35","first-page":"74","article-title":"An estimate of Lyme borreliosis incidence in Western Europe","volume":"39","author":"Sykes","year":"2017","journal-title":"J. Public Health"},{"key":"10.1016\/j.omtn.2025.102514_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104524","article-title":"Systematic comparisons between Lyme disease and post-treatment Lyme disease syndrome in the U.S. with administrative claims data","volume":"90","author":"Chung","year":"2023","journal-title":"EBioMedicine"},{"key":"10.1016\/j.omtn.2025.102514_bib37","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s13071-015-0676-x","article-title":"Immunization with a recombinant subunit OspA vaccine markedly impacts the rate of newly acquired Borrelia burgdorferi infections in client-owned dogs living in a coastal community in Maine, USA","volume":"8","author":"Eschner","year":"2015","journal-title":"Parasit. Vectors"},{"key":"10.1016\/j.omtn.2025.102514_bib38","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1093\/infdis\/162.1.133","article-title":"Lyme Borreliosis in Selected Strains and Ages of Laboratory Mice","volume":"162","author":"Barthold","year":"1990","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.omtn.2025.102514_bib39","first-page":"263","article-title":"Kinetics of Borrelia burgdorferi dissemination and evolution of disease after intradermal inoculation of mice","volume":"139","author":"Barthold","year":"1991","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.omtn.2025.102514_bib40","doi-asserted-by":"crossref","first-page":"249","DOI":"10.4269\/ajtmh.1992.47.249","article-title":"Carditis in Lyme Disease Susceptible and Resistant Strains of Laboratory Mice Infected with Borrelia Burgdorferi","volume":"47","author":"Armstrong","year":"1992","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.omtn.2025.102514_bib41","first-page":"959","article-title":"Chronic Lyme borreliosis in the laboratory mouse","volume":"143","author":"Barthold","year":"1993","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.omtn.2025.102514_bib42","doi-asserted-by":"crossref","first-page":"900","DOI":"10.4049\/jimmunol.151.2.900","article-title":"Inability of truncated recombinant Osp A proteins to elicit protective immunity to Borrelia burgdorferi in mice","volume":"151","author":"Bockenstedt","year":"1993","journal-title":"J. Immunol."},{"key":"10.1016\/j.omtn.2025.102514_bib43","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3390\/vaccines11010043","article-title":"A Retrospective Study with a Commercial Vaccine against Lyme Borreliosis in Dogs Using Two Different Vaccination Schedules: Characterization of the Humoral Immune Response","volume":"11","author":"Wilczek","year":"2022","journal-title":"Vaccines"},{"key":"10.1016\/j.omtn.2025.102514_bib44","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1093\/infdis\/167.4.971","article-title":"Mode of Inoculation of the Lyme Disease Agent Borrelia burgdorferi Influences Infection and Immune Responses in Inbred Strains of Mice","volume":"167","author":"Gern","year":"1993","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.omtn.2025.102514_bib45","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.3389\/fmicb.2018.01722","article-title":"Infection Kinetics and Tropism of Borrelia burgdorferi sensu lato in Mouse After Natural (via Ticks) or Artificial (Needle) Infection Depends on the Bacterial Strain","volume":"9","author":"Sertour","year":"2018","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.omtn.2025.102514_bib46","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2208274119","article-title":"Interference with LT\u03b2R signaling by tick saliva facilitates transmission of Lyme disease spirochetes","volume":"119","author":"Jin","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2025.102514_bib47","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s13071-016-1380-1","article-title":"Virulence of the Lyme disease spirochete before and after the tick bloodmeal: a quantitative assessment","volume":"9","author":"Kasumba","year":"2016","journal-title":"Parasit. Vectors"},{"key":"10.1016\/j.omtn.2025.102514_bib48","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1093\/infdis\/167.5.1082","article-title":"Dynamics of Borrelia burgdorferi Transmission by Nymphal Ixodes dammini Ticks","volume":"167","author":"Piesman","year":"1993","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.omtn.2025.102514_bib49","doi-asserted-by":"crossref","first-page":"eabj9827","DOI":"10.1126\/scitranslmed.abj9827","article-title":"mRNA vaccination induces tick resistance and prevents transmission of the Lyme disease agent","volume":"13","author":"Sajid","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.omtn.2025.102514_bib50","series-title":"mRNA Vaccination Targeting Tick Antigens Induces Resistance to Ixodes scapularis","first-page":"41","article-title":"16th International Conference on Lyme Borreliosis and other Tick-borne diseases (ICLB)","author":"Fikrig","year":"2022"},{"key":"10.1016\/j.omtn.2025.102514_bib51","article-title":"Case presentation and management of Lyme disease patients: a 9-year retrospective analysis in France","volume":"10","author":"Perthame","year":"2023","journal-title":"Front. Med."},{"key":"10.1016\/j.omtn.2025.102514_bib52","first-page":"96","article-title":"Efficacy of a nonadjuvanted, outer surface protein A, recombinant vaccine in dogs after challenge by ticks naturally infected with Borrelia burgdorferi","volume":"1","author":"Conlon","year":"2000","journal-title":"Vet. Ther."},{"key":"10.1016\/j.omtn.2025.102514_bib53","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1128\/IAI.71.2.822-829.2003","article-title":"Does Host Complement Kill Borrelia burgdorferi within Ticks?","volume":"71","author":"Rathinavelu","year":"2003","journal-title":"Infect. Immun."},{"key":"10.1016\/j.omtn.2025.102514_bib54","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.1002\/eji.200425719","article-title":"Decision criteria for resolving isotype switching conflicts by B cells","volume":"35","author":"Deenick","year":"2005","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.omtn.2025.102514_bib55","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/icb.2016.65","article-title":"IgG subclass co-expression brings harmony to the quartet model of murine IgG function","volume":"94","author":"Collins","year":"2016","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.omtn.2025.102514_bib56","doi-asserted-by":"crossref","first-page":"4661","DOI":"10.1128\/iai.65.11.4661-4667.1997","article-title":"Borrelia burgdorferi strain-specific Osp C-mediated immunity in mice","volume":"65","author":"Bockenstedt","year":"1997","journal-title":"Infect. Immun."},{"key":"10.1016\/j.omtn.2025.102514_bib57","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1016\/j.vaccine.2020.01.027","article-title":"Development and optimization of OspC chimeritope vaccinogens for Lyme disease","volume":"38","author":"Izac","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.omtn.2025.102514_bib58","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1111\/jvim.15085","article-title":"ACVIM consensus update on Lyme borreliosis in dogs and cats","volume":"32","author":"Littman","year":"2018","journal-title":"J. Vet. Intern. Med."},{"key":"10.1016\/j.omtn.2025.102514_bib59","article-title":"VANGUARD\u00aecrLyme: A next generation Lyme disease vaccine that prevents B. burgdorferi infection in dogs","volume":"6","author":"Marconi","year":"2020","journal-title":"Vaccine X"},{"key":"10.1016\/j.omtn.2025.102514_bib60","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1126\/science.281.5377.703","article-title":"Identification of LFA-1 as a Candidate Autoantigen in Treatment-Resistant Lyme Arthritis","volume":"281","author":"Gross","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.omtn.2025.102514_bib61","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/s41541-021-00324-5","article-title":"Immunogenicity and efficacy of mRNA COVID-19 vaccine MRT5500 in preclinical animal models","volume":"6","author":"Kalnin","year":"2021","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.omtn.2025.102514_bib62","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.ymthe.2019.03.001","article-title":"Improved Efficacy in a Fabry Disease Model Using a Systemic mRNA Liver Depot System as Compared to Enzyme Replacement Therapy","volume":"27","author":"DeRosa","year":"2019","journal-title":"Mol. Ther."}],"container-title":["Molecular Therapy Nucleic Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S216225312500068X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S216225312500068X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T04:39:32Z","timestamp":1763354372000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S216225312500068X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":62,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S216225312500068X"],"URL":"https:\/\/doi.org\/10.1016\/j.omtn.2025.102514","relation":{},"ISSN":["2162-2531"],"issn-type":[{"value":"2162-2531","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Lyme disease mRNA vaccine targeting Borrelia burgdorferi OspA induces strong immune responses and prevents transmission in mice","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Nucleic Acids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtn.2025.102514","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"102514"}}